Navigation Links
Inhaled glucocorticoids during pregnancy and offspring pediatric diseases
Date:12/15/2011

Inhaled glucocorticoids for the treatment of asthma during pregnancy are not associated with an increased risk of most diseases in offspring, but may be a risk factor for endocrine and metabolic disturbances, according to a new study.

In a population-based cohort study, 65,085 mother-child pairs from the Danish National Birth Cohort were followed up in real time from early pregnancy into childhood. "Maternal use of inhaled glucocorticoids for asthma during pregnancy was not related to an increased risk of most diseases in childhood, except for endocrine and metabolic disorders, as compared to the risk in asthmatic mothers without glucocorticoid inhalation during pregnancy," said first author Marion Tegethoff, PhD, associate faculty member in clinical psychology and psychiatry at the University of Basel, Switzerland. "Our data are mostly reassuring and support the use of inhaled glucocorticoids during pregnancy."

The findings were published online ahead of print publication in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

Of 65,085 mother-child pairs with live singleton pregnancies, 61,002 had no asthma during pregnancy (93.7%) and 4083 (6.3%) had asthma during pregnancy. Median age at end of follow-up was 6.1 years (range: 3.6 to 8.9 years). In statistical analyses adjusted for baseline predictors of child health, use (versus no use) of inhaled glucocorticoids was associated with a significantly increased risk for the first diagnosis of endocrine and metabolic disorders (hazard ratio [HR], 1.84; 95% confidence interval [CI], 1.13-2.99), but not of diseases in any other category. Results were similar when analyses were restricted to mother-child pairs exposed only to budesonide, the inhaled glucocorticoid used by the majority of women (79.9%) in the study.

"This is the first comprehensive study of potential effects of glucocorticoid inhalation during pregnancy on the health of offspring, covering a wide spectrum of pediatric diseases," said last author Gunther Meinlschmidt, PhD, associate faculty member in clinical psychology and epidemiology at the University of Basel, Switzerland. "While our results support the use of these widely used asthma treatments during pregnancy, their effect on endocrine and metabolic disturbances during childhood merits further study."

There were some limitations to the study, including a lack of data on daily inhalation doses, use of self-report of maternal asthma and the study's focus on glucocorticoid inhalation rather than other active ingredients or glucocorticoids administered by other routes.

"Our data have both clinical and public health implications," the authors concluded, "given that asthma is common in pregnant women and inhaled glucocorticoids are the recommended treatment."


'/>"/>

Contact: Nathaniel Dunford
ndunford@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Related medicine news :

1. City cyclists are at increased risk from lung injury from inhaled soot
2. Study: Long-term inhaled corticosteroid use increases fracture risk in lung disease patients
3. Asthma Pills Work as Well as Inhaled Steroids: Study
4. Inhaled Meds May Save COPD/Pneumonia Patients Lives
5. Inhaled steroids increase diabetes risk, say Lady Davis Institute researchers
6. New Inhaled Insulin Shows Promise for Diabetes
7. Majority of B.C. women take prescription drugs during pregnancy: UBC study
8. Drunk Driving-Related Deaths Surge During the Holidays
9. Mothers weight before and during pregnancy affects babys weight
10. Maryland study finds that US Hispanics were at greater risk for H1N1 flu during 2009 pandemic
11. Epileptic Seizures May Worsen During Menstrual Cycle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... The American Board of Family Medicine's (ABFM) Board of Directors has ... succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the ... at the end of 2018. Upon assuming the role of President and CEO on ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... CAESAREA, Israel and NEW YORK , Sept. ... company with mobile health and big data solutions, today announced that its ... today. Please check your local TV listings for when The Dr. Oz ... ... ninth season this month. ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology: